再生障碍性贫血(简称再障)是由于不同发病原因损害了骨髓造血功能,导致全血细胞减少的一组综合征。自从Ehlich1888年首先提出此病以来,从治疗上始终比较困难,且予后恶劣,多年来一直成为国内外血液学工作者的主要研究课题之一。近年来治疗方法也不断改进,使治疗再障的有效率由原来的30％增至80％以 Aplastic anemia (referred to as aplastic anemia) is due to different causes of damage to bone marrow hematopoietic function, leading to a group of pancytopenia syndrome. Since the first publication of Ehrlich in 1888, it has been relatively difficult to treat and worsened afterwards and has been one of the major research topics for hematology workers at home and abroad for many years. In recent years, treatment has been continuously improved, making the treatment of aplastic anemia efficiency increased from 30% to 80%